Enable Accessibility Enable Accessibility

Approved for Use in European Union

LEARN MORE

Welcome to the Global
Corporate Website for Takeda

If you are looking for specific information,
please visit our country/region website. 

 

 

 

 

 

SELECT A COUNTRY OR REGION SITE

Access to Medicine 2022 Progress Report

LEARN MORE

Earnings announcement for the 2nd quarter FY2022 (Oct 27, 2022)
LEARN MORE

Please wait...

Topics

2022 Annual Integrated Report
LEARN MORE

Andy Plump discusses maintaining trust in science.
LEARN MORE

Our Stories

LEARN MORE

Corporate Responsibility
LEARN MORE

Information

Earnings announcement for the 2nd quarter FY2022 (October 27, 2022)
Webcast for Investors, Analysts and Media, 6:30pm-8:00pm JST (Presentation and Q&A Session)

146th Ordinary General Meeting of Shareholders (June 29, 2022)

Information for US Patients Regarding the NATPARA Recall in the US

ADS Helpline

 

Sign up for emails from Takeda

Select the alerts you’d like to receive: * Indicates required field

At least one alert must be selected

Select one of the following:

Takeda will use the contact information you entered above to provide you with the investor related materials you requested. In order to best serve and effectively communicate with you, Takeda may also use your personal data for advertising purposes, such as serving you targeted advertisements related to the information you requested.  For more information on how Takeda processes your personal data and your rights related to this processing, please refer to our Privacy Notice and Terms of Use.

Copyright 1995-2022 Takeda Pharmaceutical Company Limited. All rights reserved.